BPC-157 6mg / TB-500 9mg
The classic healing duo — gut, tendon & systemic repair
Full Details & Dosage GuideClinical Uses
- Cardiovascular tissue repair
- Organ protection (liver, kidney, pancreas)
- Systemic wound healing and inflammation
- Athletic recovery and connective tissue repair
- Post-surgical healing
- Chronic disease tissue protection
Key Benefits
- Dual-pathway: BPC-157 drives angiogenesis; TB-500 drives cellular migration
- Reduces inflammation while promoting regeneration simultaneously
- Systemic reach — protects organs distant from injection site
- Significant cardioprotective effects in ischemia models
- Well-tolerated combination with decades of research
How It Works
BPC-157 stimulates VEGF-mediated angiogenesis and FAK-paxillin cellular migration, directly repairing damaged tissue microvasculature. TB-500 promotes actin polymerization through its Ac-SDKP sequence, enabling cell motility and tissue remodeling. In the cardiovascular system, BPC-157 preserves endothelial integrity post-ischemia while TB-500 supports cardiomyocyte survival and vascular remodeling.
Dosage Protocol
BPC-157: 250–500 mcg + TB-500: 500 mcg–2 mg subcutaneous injection, 1–2x daily. Co-administer at adjacent sites. Cardiovascular protocol: 4–8 weeks with cardiologist oversight.
When to Expect Results
Days 3–7: reduction in pain and inflammation. Weeks 2–3: improved tissue perfusion and healing. Weeks 4–6: measurable functional recovery. Weeks 6–8: significant organ-level regeneration and inflammatory marker normalization.
BPC-157 15mg / TB-500 22.5mg
High-dose BPC/TB combo — intensive full-body recovery protocol
Full Details & Dosage GuideClinical Uses
- Cardiovascular tissue repair
- Organ protection (liver, kidney, pancreas)
- Systemic wound healing and inflammation
- Athletic recovery and connective tissue repair
- Post-surgical healing
- Chronic disease tissue protection
Key Benefits
- Dual-pathway: BPC-157 drives angiogenesis; TB-500 drives cellular migration
- Reduces inflammation while promoting regeneration simultaneously
- Systemic reach — protects organs distant from injection site
- Significant cardioprotective effects in ischemia models
- Well-tolerated combination with decades of research
How It Works
BPC-157 stimulates VEGF-mediated angiogenesis and FAK-paxillin cellular migration, directly repairing damaged tissue microvasculature. TB-500 promotes actin polymerization through its Ac-SDKP sequence, enabling cell motility and tissue remodeling. In the cardiovascular system, BPC-157 preserves endothelial integrity post-ischemia while TB-500 supports cardiomyocyte survival and vascular remodeling.
Dosage Protocol
BPC-157: 250–500 mcg + TB-500: 500 mcg–2 mg subcutaneous injection, 1–2x daily. Co-administer at adjacent sites. Cardiovascular protocol: 4–8 weeks with cardiologist oversight.
When to Expect Results
Days 3–7: reduction in pain and inflammation. Weeks 2–3: improved tissue perfusion and healing. Weeks 4–6: measurable functional recovery. Weeks 6–8: significant organ-level regeneration and inflammatory marker normalization.
CJC 3mg / Ipamorelin 6mg
Most popular GH stack — natural GH optimization
Full Details & Dosage GuideClinical Uses
- Optimized growth hormone secretion
- Anti-aging and longevity protocols
- Body recomposition (muscle gain + fat loss)
- Injury recovery and tissue repair
- Sleep architecture improvement
Key Benefits
- Synergistic dual-pathway GH stimulation for larger, cleaner GH pulse
- Ipamorelin blocks somatostatin — removing the body's GH brake
- No cortisol or prolactin spike unlike GHRP-2/6
- Improves IGF-1 levels within 4–6 weeks
- Minimal side effects at therapeutic doses
How It Works
CJC-1295 No DAC stimulates the GHRH receptor on pituitary somatotrophs to synthesize and release GH, while Ipamorelin (a selective ghrelin mimetic/GHRP) simultaneously blocks somatostatin — the hormone that suppresses GH release. Together, they produce a synergistic GH pulse that is 2–5x larger than either peptide alone, while remaining free of cortisol or prolactin elevation.
Dosage Protocol
CJC: 100–200 mcg + Ipamorelin: 200–300 mcg subcutaneous injection 2–3x daily: morning (fasted), post-workout, and 30 minutes before sleep. 5 days on, 2 days off. Run for 3–6 months.
When to Expect Results
Week 1–2: deeper sleep and faster recovery. Weeks 3–6: noticeable body composition changes. Weeks 8–12: measurable IGF-1 increase, lean mass gain, visible fat reduction.
CJC 6mg / Ipamorelin 6mg
High-dose GH stack — maximum growth hormone release
Full Details & Dosage GuideClinical Uses
- Advanced growth hormone optimization
- Performance and body recomposition
- Longevity and anti-aging protocols
- Post-injury tissue regeneration
- Metabolic enhancement
Key Benefits
- Higher-dose CJC for those requiring stronger GH stimulus
- Extends pituitary GH-secreting capacity over time
- Significant improvement in skin elasticity and collagen synthesis
- Superior fat mobilization from visceral and subcutaneous depots
- Enhanced recovery between training sessions
How It Works
Same dual GHRH/ghrelin mechanism as the standard CJC/Ipamorelin stack, with higher CJC-1295 dosing providing more sustained pituitary stimulation. The 6mg CJC vial allows larger per-dose volumes or longer protocol duration without vial changes.
Dosage Protocol
CJC: 150–300 mcg + Ipamorelin: 200–300 mcg subcutaneous injection 2–3x daily. Best taken fasted. Rotate injection sites. 5 days on, 2 days off. Run labs at 6-week intervals.
When to Expect Results
Weeks 1–2: sleep improvement and reduced soreness. Weeks 4–6: body composition shifts, increased IGF-1. Weeks 8–12: visible lean mass increase and visceral fat reduction.
CJC / Ipamorelin / DSIP
Triple stack — GH optimization + deep sleep synergy
Full Details & Dosage GuideClinical Uses
- Comprehensive sleep, recovery, and GH optimization
- Anti-aging night protocol
- Post-competition athlete recovery
- Adrenal fatigue and overtraining syndrome
- Systemic regeneration during sleep
Key Benefits
- Triple-mechanism nighttime stack: GH release + somatostatin blockade + deep sleep induction
- Maximizes the anabolic growth hormone window during sleep
- Reduces cortisol while boosting GH
- Improves body composition, recovery, and cognitive performance simultaneously
- No significant interaction risks
How It Works
CJC-1295 No DAC stimulates GHRH receptor for GH synthesis; Ipamorelin blocks somatostatin to remove the GH brake; DSIP promotes delta wave sleep and HPA axis normalization. Together they create the optimal neuroendocrine environment for nighttime regeneration — high GH, low cortisol, deep sleep.
Dosage Protocol
CJC: 100–200 mcg + Ipamorelin: 200–300 mcg + DSIP: 100–200 mcg. All subcutaneous 30–45 minutes before sleep. 5 days on, 2 days off. Run for 3–6 months.
When to Expect Results
Night 1–3: significantly deeper sleep. Weeks 1–2: improved morning energy and recovery. Weeks 4–8: body composition shifts, improved IGF-1. Weeks 8–16: full anti-aging and regenerative effect.
GLOW Triple Peptide (BPC + TB + GHK)
GHH signature beauty & repair stack — skin, hair & systemic healing
Full Details & Dosage GuideClinical Uses
- Comprehensive skin and hair rejuvenation
- Wound and scar healing
- Post-procedure aesthetic recovery
- Systemic anti-aging with skin focus
- Hair restoration combined with skin health
Key Benefits
- Triple-mechanism: repair (BPC-157) + remodeling (TB-500) + collagen synthesis (GHK-Cu)
- GHH's exclusive aesthetic recovery formulation
- Works on skin, hair, nails, and connective tissue simultaneously
- Significantly faster recovery from aesthetic procedures
- One vial replaces three separate peptide orders
How It Works
GLOW combines BPC-157 (angiogenesis, cellular migration, wound healing), TB-500 (actin polymerization, cell motility, regeneration), and GHK-Cu (collagen/elastin synthesis, antioxidant repair, hair follicle activation). Together, these three peptides activate every major pathway of skin and hair regeneration.
Dosage Protocol
1–2 mg total subcutaneous injection daily or every other day. Combine with topical GHK-Cu serum. 6–12 week systemic protocol. Maintenance: 2–3x per week.
When to Expect Results
Week 1–2: improved skin hydration. Weeks 2–4: visible wound/scar healing acceleration. Weeks 4–8: collagen remodeling, hair density improvement. Weeks 8–12: full skin rejuvenation and hair restoration.
KLOW Peptide (BPC + TB + KPV)
GHH anti-inflammatory gut & immune stack
Full Details & Dosage GuideClinical Uses
- Inflammatory bowel disease (Crohn's, UC)
- Systemic inflammatory condition with gut involvement
- Post-surgical gut and systemic repair
- Leaky gut with chronic inflammation
- Autoimmune GI disease management
Key Benefits
- Triple anti-inflammatory + repair mechanism unique to GHH
- BPC-157 repairs gut structure; TB-500 drives cell migration; KPV blocks NF-κB inflammation
- Comprehensive IBD management without immunosuppression
- Works locally in the gut and systemically
- Suitable for patients who cannot tolerate conventional IBD biologics
How It Works
KLOW combines BPC-157 (mucosal angiogenesis and repair via FAK-paxillin), TB-500 (epithelial cell migration via actin polymerization), and KPV (NF-κB anti-inflammatory action via melanocortin receptors). This covers all three therapeutic targets in IBD: structural repair, cell regeneration, and cytokine suppression — without systemic immunosuppression.
Dosage Protocol
Oral (GI effect): each peptide 250–500 mcg twice daily fasted. Subcutaneous (systemic): 500 mcg–1 mg per peptide once daily. 8–12 week protocol. Monitor CRP, calprotectin, and symptom scores.
When to Expect Results
Days 3–7: reduced GI inflammation and urgency. Weeks 2–4: improved stool consistency. Weeks 4–8: mucosal healing measurable. Weeks 8–12: sustained remission.
KLOW Peptide + GHK-Cu
KLOW plus copper peptide — advanced gut healing with skin regeneration
Full Details & Dosage GuideClinical Uses
- IBD with skin or hair concerns
- Autoimmune disease with inflammatory and skin manifestations
- Comprehensive systemic anti-inflammatory + regenerative protocol
- Post-surgical gut + skin recovery
Key Benefits
- KLOW provides GI and systemic anti-inflammatory repair; GHK-Cu adds skin, hair, and collagen restoration
- Complete systemic protocol covering gut, skin, and connective tissue
- Four active peptides in one stack — remarkable therapeutic breadth
- GHK-Cu complements KLOW's IBD management
- Addresses internal and external manifestations of chronic inflammation
How It Works
KLOW's BPC-157/TB-500/KPV trio handles structural gut repair, cell migration, and NF-κB anti-inflammatory action. GHK-Cu adds collagen/elastin synthesis, antioxidant repair, and hair follicle activation. Particularly valuable for IBD patients with concurrent skin manifestations like pyoderma gangrenosum.
Dosage Protocol
KLOW peptides: 500 mcg each twice daily (oral or SC). GHK-Cu: 1 mg subcutaneous daily + topical serum. 8–12 week protocol. Reassess at 6 weeks.
When to Expect Results
Weeks 2–4: GI improvement and skin hydration. Weeks 4–8: collagen improvement and hair density increase. Full benefit at 12 weeks.
PT-141 + Oxytocin Advanced 15mg + 600IU
The ultimate intimacy stack — libido + bonding hormone
Full Details & Dosage GuideClinical Uses
- Enhanced sexual desire with deep emotional bonding
- Couples intimacy optimization
- Female sexual dysfunction with relational component
- Psychogenic sexual dysfunction
Key Benefits
- PT-141 drives central arousal; oxytocin creates profound emotional connection
- Synergistic enhancement of physical and psychological aspects of sexuality
- Oxytocin reduces performance anxiety
- Improved partner bonding and trust response
How It Works
PT-141 activates hypothalamic MC4R for sexual arousal. Oxytocin reduces amygdala fear responses and enhances limbic bonding. Together they address both desire and emotional safety — the full spectrum of sexual wellness.
Dosage Protocol
PT-141: 1–2 mg SC + Oxytocin: 40–80 IU intranasal, both 45–60 min before activity. Single use as needed.
When to Expect Results
Onset 45–60 min. Peak 90–120 min. Duration 6–10 hours. Oxytocin bonding effect from 10–15 min.
Semax + Selank 30mg + 30mg
Cognitive + anxiety relief nasal combo
Full Details & Dosage GuideClinical Uses
- Combined cognitive enhancement and anxiety reduction
- Neurological recovery with mood support
- Executive function and emotional regulation
- Chronic stress with cognitive impairment
- Peak cognitive performance
Key Benefits
- Dual-mechanism: BDNF upregulation + GABAergic anxiety modulation
- Semax sharpens focus; Selank reduces mental noise and anxiety
- Neither causes sedation — both maintain full alertness
- Synergistic neuroprotection against oxidative and excitotoxic damage
- Decades of clinical use in Russia
How It Works
Semax drives cognitive performance by upregulating BDNF and activating serotonergic/dopaminergic circuits. Selank reduces anxiety through GABAergic modulation and enkephalin stabilization. Together they create a 'flow state' neurochemical environment: high arousal + low anxiety = optimal performance.
Dosage Protocol
Semax 300 mcg + Selank 300 mcg intranasal, applied separately to alternating nostrils, 1–2x daily. 2–4 week cycles with 1–2 week breaks.
When to Expect Results
Day 1: improved mood stability and sharper focus. Week 1–2: reduced anxiety with enhanced productivity. Weeks 3–4: measurable cognitive performance gains. Weeks 4–8: sustained neuroplasticity improvements.
All peptides require UAE licensed physician review and mandatory blood work before dispensing. All protocols are subject to physician approval. Results vary by individual. These statements are for informational purposes only and do not constitute medical advice.